Retraction notice: “MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway”
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
SAGE Publishing
2025-03-01
|
| Series: | Clinical Medicine Insights: Oncology |
| Online Access: | https://doi.org/10.1177/11795549251328453 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PI3K/AKT/mTOR Signaling Pathway Is Downregulated by Runzaoling (RZL) in Sjögren’s Syndrome
by: Ping Zeng, et al.
Published: (2022-01-01) -
NR4A3 suppresses bladder cancer progression by modulating autophagy via the PI3K/AKT/mTOR pathway
by: Li Fan, et al.
Published: (2025-06-01) -
Mechanism of electroacupuncture on rats with primary dysmenorrhea based on microRNA expression spectrum and PI3K/Akt/mTOR signaling pathway
by: Si-an PAN, et al.
Published: (2025-04-01) -
The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma
by: Ilaria Versari, et al.
Published: (2025-02-01) -
PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment
by: Mingyang Jiang, et al.
Published: (2025-08-01)